---
provider: cyberian
model: deep-research
cached: false
start_time: '2026-01-24T00:13:44.971479'
end_time: '2026-01-24T00:26:42.036402'
duration_seconds: 777.06
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: VOPP1
  gene_symbol: VOPP1
  uniprot_accession: Q96AW1
  protein_description: 'RecName: Full=WW domain binding protein VOPP1 {ECO:0000312|HGNC:HGNC:34518};
    AltName: Full=EGFR-coamplified and overexpressed protein {ECO:0000303|PubMed:20571887};
    Short=ECop {ECO:0000303|PubMed:20571887}; AltName: Full=Glioblastoma-amplified
    secreted protein; AltName: Full=Putative NF-kappa-B-activating protein 055N; AltName:
    Full=Vesicular, overexpressed in cancer, prosurvival protein 1; Flags: Precursor;'
  gene_info: Name=VOPP1 {ECO:0000312|HGNC:HGNC:34518}; Synonyms=ECOP, GASP;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the VOPP1/ECOP family. .
  protein_domains: VOPP1. (IPR026229)
provider_config:
  timeout: 1800
  max_retries: 3
  parameters:
    allowed_domains: []
    agent_type: claude
    port: 3284
    skip_permissions: true
citation_count: 15
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96AW1
- **Protein Description:** RecName: Full=WW domain binding protein VOPP1 {ECO:0000312|HGNC:HGNC:34518}; AltName: Full=EGFR-coamplified and overexpressed protein {ECO:0000303|PubMed:20571887}; Short=ECop {ECO:0000303|PubMed:20571887}; AltName: Full=Glioblastoma-amplified secreted protein; AltName: Full=Putative NF-kappa-B-activating protein 055N; AltName: Full=Vesicular, overexpressed in cancer, prosurvival protein 1; Flags: Precursor;
- **Gene Information:** Name=VOPP1 {ECO:0000312|HGNC:HGNC:34518}; Synonyms=ECOP, GASP;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the VOPP1/ECOP family. .
- **Key Domains:** VOPP1. (IPR026229)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "VOPP1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'VOPP1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **VOPP1** (gene ID: VOPP1, UniProt: Q96AW1) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# VOPP1 (Q96AW1): A Comprehensive Functional Annotation Report

## Introduction and Overview

VOPP1 (Vesicular, Overexpressed in cancer, Pro-survival Protein 1), also known as ECOP (EGFR-Coamplified and Overexpressed Protein) and GASP (Glioblastoma-Amplified Secreted Protein), is a human protein encoded by the VOPP1 gene located at chromosomal position 7p11.2. This gene is frequently co-amplified with EGFR in various cancers, particularly glioblastoma multiforme [park-2005-ecop-nfkb-abstract]. The VOPP1 protein functions as a pro-survival factor that confers resistance to apoptosis in cancer cells, though the precise molecular mechanisms through which it exerts this function have been a subject of ongoing investigation and some debate in the literature.

The VOPP1 protein is characterized by a signal sequence, a transmembrane domain, and multiple proline-rich PPxY motifs in its C-terminal region that mediate critical protein-protein interactions [bonin-2018-vopp1-wwox-breast-fulltext]. According to PubMed, the protein contains endosome/lysosome targeting sequences, including a YXXφ motif and a dileucine sequence, which dictate its vesicular localization [baras-2010-localization-abstract]. The protein belongs to the VOPP1/ECOP family and possesses the VOPP1 domain (InterPro: IPR026229), though this domain lacks obvious enzymatic or well-characterized structural features that would immediately suggest a specific molecular function.

The primary molecular role of VOPP1 appears to be as an adapter or regulatory protein that modulates apoptotic signaling pathways. Two principal mechanisms have been proposed: regulation of NF-κB signaling and interaction with the tumor suppressor protein WWOX. Additionally, VOPP1 appears to participate in the control of intracellular redox homeostasis. This report synthesizes the available literature to provide a comprehensive understanding of VOPP1 function, localization, and biological significance.

## Subcellular Localization and Membrane Topology

The subcellular localization of VOPP1 has been carefully characterized through multiple studies. Despite the presence of a signal sequence that initially suggested VOPP1 might be a secreted protein (hence its early name "Glioblastoma-Amplified Secreted Protein"), experimental evidence has definitively established that VOPP1 is not secreted and is retained intracellularly [baras-2010-localization-abstract].

According to PubMed, analysis of VOPP1 sequence structure reveals both a signal sequence and a transmembrane domain. Examination of microarray datasets for endoplasmic reticulum (ER)-bound mRNA transcripts is consistent with the VOPP1 protein being synthesized into the ER ([DOI](https://doi.org/10.1007/s10735-010-9272-8)). Immunoblot analysis of cell culture and conditioned media confirms that the protein product is not secreted but retained within the cell [baras-2010-localization-abstract].

VOPP1 displays a distinctive intracellular vesicular pattern of localization. Co-localization experiments using fluorescence microscopy revealed that VOPP1-positive vesicles do not co-localize with mitochondria or peroxisomes, but show partial co-localization with perinuclear lysosomes [baras-2010-localization-abstract]. Additionally, markers of endocytosis and autophagy show partial perinuclear co-localization, suggesting that VOPP1-containing vesicles enter final common pathways of the lysosomal system.

The vesicular/lysosomal localization of VOPP1 was confirmed in multiple cell types, including breast cancer cells and gastric cancer cells [bonin-2018-vopp1-wwox-breast-fulltext][gao-2015-ecop-gastric-oncogene-abstract]. In MDA-MB-468 breast cancer cells, endogenous VOPP1 showed clear co-localization with LAMP2 (a lysosomal marker) in perinuclear regions [bonin-2018-vopp1-wwox-breast-fulltext]. This consistent localization pattern across different cell types and experimental approaches strongly establishes the late endosomal/lysosomal compartment as the primary site of VOPP1 function.

## NF-κB Pathway Regulation

The initial characterization of VOPP1/ECOP function was performed by Park and James (2005), who reported that ECOP regulates NF-κB transcriptional activity in an IκBα-dependent manner ([DOI](https://doi.org/10.1038/sj.onc.1208496)) [park-2005-ecop-nfkb-abstract]. According to PubMed, ectopic expression of ECop increases NF-κB transcriptional activity by promoting nuclear translocation and DNA binding of NF-κB. In ECop knockdown cells, NF-κB transcriptional activity is suppressed due to delayed IκBα degradation, which results in delayed nuclear translocation as well as decreased DNA binding of NF-κB.

This initial model proposed that ECOP might interact directly with cytoplasmic mediators of the NF-κB pathway. However, subsequent studies raised questions about this mechanism. Baras and Moskaluk (2010) noted that the vesicular/lysosomal localization of VOPP1 "throws into doubt the hypothesis that VOPP1 interacts directly with cytoplasmic mediators of the NF-κB pathway" [baras-2010-localization-abstract]. The physical segregation of VOPP1 in vesicular compartments seemed incompatible with direct interaction with IκBα and other cytoplasmic NF-κB regulators.

Further complicating the picture, Baras et al. (2011) found that reporter constructs for NF-κB-mediated transcription were not affected in squamous cell carcinoma (SCC) cell lines by VOPP1 knockdown ([DOI](https://doi.org/10.1038/labinvest.2011.70)) [baras-2011-oxidative-abstract]. This suggested that the relationship between VOPP1 and NF-κB might be cell-type specific or that the pro-survival effect of VOPP1 could be mediated through alternative mechanisms.

Despite these caveats, multiple subsequent studies have continued to implicate VOPP1/ECOP in NF-κB signaling. Xia et al. (2013) demonstrated that miR-218 sensitizes glioma cells to apoptosis by targeting ECOP and suppressing NF-κB activity ([DOI](https://doi.org/10.1093/neuonc/nos296)) [xia-2013-mir218-glioma-abstract]. Ectopic expression of ECOP rescued glioma cells from miR-218-induced apoptosis and increased NF-κB activity, supporting a functional link between ECOP and NF-κB in this context. Similarly, Gao et al. (2010) identified ECOP as a direct target of miR-218 in gastric cancer and showed that miR-218 overexpression inhibited NF-κB transcriptional activation ([DOI](https://doi.org/10.1002/cncr.24743)) [gao-2010-mir218-gastric-abstract].

One possible reconciliation of these findings is that VOPP1 may affect NF-κB signaling indirectly through its interaction with WWOX, which has itself been suggested to interact with IκBα [bonin-2018-vopp1-wwox-breast-fulltext]. Alternatively, the NF-κB effects may be secondary to VOPP1's role in oxidative stress regulation, as ROS levels can modulate NF-κB activity.

## Interaction with WWOX Tumor Suppressor

Perhaps the most significant advance in understanding VOPP1 function came from the discovery of its interaction with WWOX (WW domain-containing oxidoreductase), a tumor suppressor protein. Bonin et al. (2018) identified VOPP1 as a new molecular partner of WWOX through yeast two-hybrid screening ([DOI](https://doi.org/10.1186/s12915-018-0576-6)) [bonin-2018-vopp1-wwox-breast-fulltext]. This interaction was validated by co-immunoprecipitation in both HEK-293T cells and MDA-MB-468 breast cancer cells, confirming that endogenous WWOX and VOPP1 are physically associated.

The molecular basis of the WWOX-VOPP1 interaction has been characterized in detail. WWOX contains two N-terminal WW domains (WW1 and WW2), with WW1 being the predominant functional interacting domain. WW1 belongs to Group I WW domains that specifically recognize proteins with PPxY consensus motifs [bonin-2018-vopp1-wwox-breast-fulltext]. VOPP1 contains three such PPxY motifs in its proline-rich C-terminal region: PPYY, PPAY, and PPPY. Mutagenesis studies demonstrated that the PPPY motif (specifically tyrosine 165) is required to sustain robust interaction with WWOX. Conversely, the Y33R mutation in the WW1 domain of WWOX abolished the WWOX-VOPP1 interaction [bonin-2018-vopp1-wwox-breast-fulltext].

The WWOX-VOPP1 interaction was independently confirmed by Hussain et al. (2018), who identified VOPP1 as a high-confidence WWOX interactor (interaction score 0.51) through tandem affinity purification-mass spectrometry (TAP-MS) ([DOI](https://doi.org/10.3389/fonc.2018.00591)) [hussain-2018-wwox-interactome-fulltext]. VOPP1 ranked among the top interacting proteins containing PPXY motifs.

The functional consequence of the WWOX-VOPP1 interaction is remarkable: VOPP1 sequesters WWOX in lysosomal vesicles. Normally, WWOX localizes to the Golgi apparatus. However, when co-expressed with VOPP1, WWOX completely loses its typical Golgi distribution and exhibits a punctate pattern consistent with lysosomal structures [bonin-2018-vopp1-wwox-breast-fulltext]. In MDA-MB-468 cells with endogenous VOPP1 expression, WWOX was found co-localized with VOPP1 and LAMP2 in perinuclear lysosomes rather than in the Golgi. Importantly, knockdown of VOPP1 in these cells induced re-localization of WWOX from lysosomal vesicles to the Golgi apparatus, demonstrating that VOPP1 is actively sequestering WWOX.

This sequestration has profound functional implications. WWOX is known to promote apoptosis through interaction with p73α, a pro-apoptotic transcription factor. The cytoplasmic WWOX-p73α complex induces apoptosis independently of p73 transcriptional activity [bonin-2018-vopp1-wwox-breast-fulltext]. VOPP1 disrupts this pro-apoptotic axis: ectopic expression of wild-type VOPP1 (but not the VOPP1-Y165A mutant that cannot bind WWOX) impaired the ability of WWOX to associate with p73α. Thus, VOPP1 inhibits WWOX-dependent apoptosis at least in part by preventing the WWOX-p73α interaction.

## Role in Oxidative Stress and Redox Homeostasis

An alternative or complementary mechanism for VOPP1's pro-survival function emerged from studies by Baras et al. (2011), who investigated VOPP1 function in squamous cell carcinoma [baras-2011-oxidative-abstract]. According to PubMed, VOPP1 knockdown induces cell death at 72 hours post-transfection through induction of apoptosis via the intrinsic (mitochondrial) pathway.

Gene expression profiling of VOPP1 knockdown cells revealed enrichment in annotations of oxidative stress and mitochondrial dysfunction [baras-2011-oxidative-abstract]. Specifically, reactive oxygen species (ROS) levels became elevated and mitochondrial membrane potential was disrupted with VOPP1 knockdown at time points preceding the activation of effector caspases and cell death. This temporal sequence suggests that oxidative stress is a causative factor rather than a consequence of apoptosis.

Crucially, the antioxidant N-acetyl cysteine (NAC) was able to abrogate the induction of apoptosis observed with VOPP1 knockdown in a dose-responsive manner [baras-2011-oxidative-abstract]. This pharmacological rescue experiment provides strong evidence that VOPP1 participates in the control of the intracellular redox state, and that its loss leads to oxidative cellular injury culminating in cell death by the intrinsic apoptotic pathway.

This redox-regulatory function aligns with the lysosomal localization of VOPP1, as lysosomes are increasingly recognized as important regulators of cellular metabolism and redox balance. Interestingly, Kertai et al. (2016) found that VOPP1 was the most significantly upregulated gene in patients with postoperative atrial fibrillation after coronary artery bypass surgery, and gene set enrichment analysis highlighted VOPP1's role in pathways related to "myocardial homeostasis, and oxidative stress and redox modulation" ([DOI](https://doi.org/10.1016/j.yjmcc.2016.02.006)) [kertai-2016-vopp1-atrial-fibrillation-abstract]. This unexpected finding in cardiac tissue suggests that VOPP1's role in redox regulation may have physiological relevance beyond cancer.

The relationship between VOPP1's role in oxidative stress and its interaction with WWOX may be interconnected. According to Bonin et al. (2018), increased ROS levels were observed in WWOX-overexpressing larvae in a Drosophila model, while WWOX mutants had consistently lower levels of ROS [bonin-2018-vopp1-wwox-breast-fulltext]. Thus, VOPP1's sequestration of WWOX might indirectly affect cellular ROS levels, providing a mechanistic link between the two pathways.

## Regulation by MicroRNAs

VOPP1/ECOP expression is negatively regulated by several microRNAs, most notably miR-218. This regulatory relationship has been demonstrated in multiple cancer types and provides important insights into VOPP1's role in tumorigenesis.

In gastric cancer, Gao et al. (2010) showed that miR-218 expression was significantly reduced in gastric cancer tissues and in Helicobacter pylori-infected gastric mucosa ([DOI](https://doi.org/10.1002/cncr.24743)) [gao-2010-mir218-gastric-abstract]. ECOP was identified as a direct target of miR-218 through luciferase reporter assays. Overexpression of miR-218 inhibited cell proliferation, increased apoptosis, and suppressed NF-κB transcriptional activation. The authors proposed that H. pylori infection leads to decreased miR-218 expression, which in turn increases ECOP levels and NF-κB activity, contributing to gastric carcinogenesis.

In glioma, Xia et al. (2013) demonstrated that miR-218 was downregulated in human glioma specimens, and overexpression of miR-218 induced glioma cell apoptosis and inhibited proliferation and tumorigenicity ([DOI](https://doi.org/10.1093/neuonc/nos296)) [xia-2013-mir218-glioma-abstract]. ECOP was validated as a functional downstream target, and ectopic expression of ECOP rescued glioma cells from miR-218-induced apoptosis.

In lung adenocarcinoma, Li et al. (2017) showed that miR-218 suppresses epithelial-to-mesenchymal transition (EMT) by targeting both ECOP and Robo1 ([DOI](https://doi.org/10.2217/fon-2017-0398)) [li-2017-mir218-lung-emt-abstract]. The suppression of ECOP by miR-218 reduced NF-κB activity and its downstream targets, inhibiting cell migration and invasion.

Beyond miR-218, VOPP1/ECOP has been identified as a target of the cellular microRNA Hs_154, which is induced by West Nile virus infection. Smith et al. (2012) found that ECOP/VOPP1 expression was reduced in WNV-infected cells due to Hs_154 upregulation, and expression of ECOP in infected cells reduced the number of cells undergoing apoptosis ([DOI](https://doi.org/10.1128/JVI.06883-11)) [smith-2012-wnv-mirna-abstract]. This finding confirms VOPP1's role as an anti-apoptotic factor and demonstrates that modulation of its expression can influence cell survival in the context of viral infection.

## Role in Cancer

VOPP1 is overexpressed in multiple human malignancies, consistent with its pro-survival function. The VOPP1 gene is located at 7p11.2, a region frequently amplified in cancers, often along with EGFR [park-2005-ecop-nfkb-abstract]. Expression profiling using the Oncomine database has revealed elevated VOPP1 transcript levels in glioblastoma multiforme, squamous cell carcinoma, breast carcinoma, pancreatic carcinoma, gastric carcinoma, and lymphoma [baras-2010-localization-abstract].

In breast cancer, Bonin et al. (2018) found that 25% of breast tumors (112/448) showed VOPP1 overexpression (≥2.5-fold increase compared to normal breast tissue) ([DOI](https://doi.org/10.1186/s12915-018-0576-6)) [bonin-2018-vopp1-wwox-breast-fulltext]. Increased expression was observed across all molecular subtypes (luminal A, luminal B, ERBB2, and triple-negative), with ERBB2 tumors showing slightly higher amounts. Importantly, gene amplification at 7p11.2 was observed only in triple-negative tumors, indicating that other mechanisms (transcriptional regulation, epigenetic changes) drive VOPP1 overexpression in most breast cancers.

The clinical significance of VOPP1 overexpression was most evident when considered in relation to WWOX status. High VOPP1 expression was significantly associated with reduced metastasis-free survival in luminal B breast tumors (log-rank p=0.005) [bonin-2018-vopp1-wwox-breast-fulltext]. Moreover, there was a negative correlation between WWOX underexpression and VOPP1 overexpression. The VOPP1/WWOX ratio was a highly significant prognostic variable (p<0.00001) with a hazard ratio of 3.2 for metastasis. Strikingly, the authors estimated that 81.69% of breast tumors are affected by alterations in the WWOX pathway, either through WWOX underexpression or VOPP1 overexpression.

Functional studies support an oncogenic role for VOPP1. Stable expression of VOPP1 in NIH3T3 cells induced morphological transformation, anchorage-independent growth in soft agar, and tumor formation in vivo [bonin-2018-vopp1-wwox-breast-fulltext]. In gastric cancer, VOPP1 overexpression promoted cell proliferation and migration [gao-2015-ecop-gastric-oncogene-abstract].

## Tissue Expression and Database Annotations

Analysis of tissue expression data from the Human Protein Atlas reveals that VOPP1 exhibits a distinctive tissue distribution pattern in normal human tissues. The highest expression is found in the retina (233.4 nTPM), with particularly striking cell type-enhanced expression in photoreceptor cells: cone photoreceptors show the highest expression (1,262.8 nCPM), followed by rod photoreceptors (841.0 nCPM) [human-protein-atlas]. This marked expression in photoreceptors is unexpected given the literature focus on cancer and suggests potential physiological functions in retinal biology that have not been explored.

VOPP1 also shows substantial expression in lymphoid tissues, including thymus (106.5 nTPM), lymph node (92.9 nTPM), tonsil (73.6 nTPM), and spleen (72.7 nTPM) [human-protein-atlas]. In the brain, notable expression is observed in the thalamus (121.7 nTPM). At the single-cell level, elevated expression is also observed in plasma cells, dendritic cells, and neutrophils, suggesting a role in immune cell function. This expression pattern led to the classification of VOPP1 in the "Retina & Lymphoid tissues - Signaling" expression cluster [human-protein-atlas].

The OMIM database entry for VOPP1 (OMIM: 611915) notes that in normal tissues, ECOP expression is strongest in thymus and ovary, with moderate levels in spleen, testes, colon, and small intestine, and weaker expression in placenta, prostate, and liver [omim-611915]. The database also notes that ECOP possesses "a signal peptide and is generally hydrophilic," with multiple transcript variants (3.6-kb and 4.2-kb forms) detected.

The Gene Ontology annotations for VOPP1 include molecular function terms related to enzyme binding activity, and cellular component terms placing the protein in cytoplasmic vesicle membrane, late endosome, and lysosome compartments [genecards]. These annotations are consistent with the experimental localization studies described above. The biological process annotations remain limited, reflecting the ongoing uncertainty about VOPP1's precise molecular function.

## Role in Non-Cancer Conditions

Emerging evidence suggests that VOPP1 may play roles beyond cancer. Kertai et al. (2016) identified VOPP1 as the most significantly differentially expressed gene (1.83 fold change; P=3.47×10^-7) in patients with postoperative atrial fibrillation (AF) after coronary artery bypass grafting ([DOI](https://doi.org/10.1016/j.yjmcc.2016.02.006)) [kertai-2016-vopp1-atrial-fibrillation-abstract]. Expression quantitative trait loci (eQTL) analysis revealed a trans-acting association between variants of the G protein-coupled receptor kinase 5 (GRK5) gene and high VOPP1 expression. These findings suggest that VOPP1 may play a role in cardiac homeostasis, potentially through its effects on oxidative stress.

Li et al. (2018) reported that miR-218 expression was reduced in peripheral blood mononuclear cells of sepsis patients, and this reduction correlated with disease severity ([DOI](https://doi.org/10.26355/eurrev_201809_15827)) [li-2018-mir218-sepsis-abstract]. VOPP1 was identified as a miR-218 target in this context, and the miR-218/VOPP1 axis was linked to JAK/STAT pathway regulation and inflammatory cytokine production. This suggests that VOPP1 may participate in immune regulation and inflammatory responses.

## Open Questions

Several important questions regarding VOPP1 function remain to be addressed:

1. **Mechanism of NF-κB regulation:** The precise mechanism by which VOPP1 affects NF-κB signaling remains unclear. Given VOPP1's vesicular localization, direct interaction with cytoplasmic NF-κB pathway components seems unlikely. Whether VOPP1 affects NF-κB indirectly through WWOX, through redox regulation, or through an unknown intermediate requires clarification.

2. **Enzymatic or catalytic function:** Despite the presence of identifiable domains, no enzymatic or catalytic activity has been attributed to VOPP1. Whether the protein functions purely as an adapter/scaffolding protein or possesses undiscovered enzymatic activity remains unknown.

3. **Lysosomal function:** The molecular function of VOPP1 within lysosomes is not understood. Does VOPP1 regulate lysosomal activity, autophagy, or protein degradation pathways? The presence of endosome/lysosome targeting sequences suggests active sorting to this compartment, but the purpose of this localization beyond WWOX sequestration is unclear.

4. **Specificity of WWOX interaction:** While the VOPP1-WWOX interaction is well characterized, it is not clear whether VOPP1 affects other WWOX functions beyond apoptosis, such as DNA damage response or metabolic regulation. WWOX has many interacting partners and pleiotropic functions.

5. **Tissue-specific functions:** The unexpected role of VOPP1 in atrial fibrillation suggests tissue-specific functions that may extend beyond its established role in cancer. Systematic characterization of VOPP1 expression and function in different tissues would be valuable.

6. **Therapeutic potential:** Given the oncogenic role of VOPP1 and its mechanism of action through WWOX sequestration, disrupting the VOPP1-WWOX interaction could potentially restore WWOX tumor suppressor function. Whether this interaction is amenable to pharmacological disruption and whether such intervention would have therapeutic benefit remains to be investigated.

7. **Relationship between oxidative stress and WWOX:** The connection between VOPP1's role in redox regulation and its interaction with WWOX needs further exploration. Do these represent independent mechanisms or are they functionally linked?

8. **Function in photoreceptors:** The Human Protein Atlas reveals striking expression of VOPP1 in cone and rod photoreceptors, with these cells showing the highest single-cell expression levels of any cell type examined. The function of VOPP1 in photoreceptors is entirely unexplored and represents a significant gap in understanding the normal physiological role of this protein.

## References

- **park-2005-ecop-nfkb**: Park S, James CD. ECop (EGFR-coamplified and overexpressed protein), a novel protein, regulates NF-kappaB transcriptional activity and associated apoptotic response in an IkappaBalpha-dependent manner. Oncogene. 2005;24(15):2495-502. PMID: 15735698. DOI: [10.1038/sj.onc.1208496](https://doi.org/10.1038/sj.onc.1208496)

- **baras-2010-localization**: Baras A, Moskaluk CA. Intracellular localization of GASP/ECOP/VOPP1. J Mol Histol. 2010;41(2-3):153-64. PMID: 20571887. DOI: [10.1007/s10735-010-9272-8](https://doi.org/10.1007/s10735-010-9272-8)

- **baras-2011-oxidative**: Baras AS, Solomon A, Davidson R, Moskaluk CA. Loss of VOPP1 overexpression in squamous carcinoma cells induces apoptosis through oxidative cellular injury. Lab Invest. 2011;91(8):1170-80. PMID: 21519330. DOI: [10.1038/labinvest.2011.70](https://doi.org/10.1038/labinvest.2011.70)

- **bonin-2018-vopp1-wwox-breast**: Bonin F, Taouis K, Azorin P, et al. VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX. BMC Biol. 2018;16(1):109. PMID: 30285739. PMC: PMC6169085. DOI: [10.1186/s12915-018-0576-6](https://doi.org/10.1186/s12915-018-0576-6)

- **hussain-2018-wwox-interactome**: Hussain T, Lee J, Abba MC, Chen J, Aldaz CM. Delineating WWOX Protein Interactome by Tandem Affinity Purification-Mass Spectrometry: Identification of Top Interactors and Key Metabolic Pathways Involved. Front Oncol. 2018;8:591. PMID: 30619736. PMC: PMC6300487. DOI: [10.3389/fonc.2018.00591](https://doi.org/10.3389/fonc.2018.00591)

- **xia-2013-mir218-glioma**: Xia H, Yan Y, Hu M, et al. MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity. Neuro Oncol. 2013;15(4):413-22. PMID: 23243056. PMC: PMC3607258. DOI: [10.1093/neuonc/nos296](https://doi.org/10.1093/neuonc/nos296)

- **gao-2010-mir218-gastric**: Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer. 2010;116(1):41-9. PMID: 19890957. DOI: [10.1002/cncr.24743](https://doi.org/10.1002/cncr.24743)

- **gao-2015-ecop-gastric-oncogene**: Gao C, Pang M, Zhou Z, et al. Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer. Clin Exp Med. 2015;15(4):469-75. PMID: 25398664. DOI: [10.1007/s10238-014-0320-7](https://doi.org/10.1007/s10238-014-0320-7)

- **smith-2012-wnv-mirna**: Smith JL, Grey FE, Uhrlaub JL, Nikolich-Zugich J, Hirsch AJ. Induction of the cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors. J Virol. 2012;86(9):5278-87. PMID: 22345437. PMC: PMC3347395. DOI: [10.1128/JVI.06883-11](https://doi.org/10.1128/JVI.06883-11)

- **kertai-2016-vopp1-atrial-fibrillation**: Kertai MD, Qi W, Li YJ, et al. Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers. J Mol Cell Cardiol. 2016;92:109-15. PMID: 26860460. PMC: PMC4967350. DOI: [10.1016/j.yjmcc.2016.02.006](https://doi.org/10.1016/j.yjmcc.2016.02.006)

- **li-2017-mir218-lung-emt**: Li YJ, Zhang W, Xia H, et al. miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells. Future Oncol. 2017;13(28):2571-2582. PMID: 28936884. DOI: [10.2217/fon-2017-0398](https://doi.org/10.2217/fon-2017-0398)

- **li-2018-mir218-sepsis**: Li JM, Zhang H, Zuo YJ. MicroRNA-218 alleviates sepsis inflammation by negatively regulating VOPP1 via JAK/STAT pathway. Eur Rev Med Pharmacol Sci. 2018;22(17):5620-5626. PMID: 30229837. DOI: [10.26355/eurrev_201809_15827](https://doi.org/10.26355/eurrev_201809_15827)

- **human-protein-atlas**: VOPP1 protein expression summary. The Human Protein Atlas. URL: [https://www.proteinatlas.org/ENSG00000154978-VOPP1](https://www.proteinatlas.org/ENSG00000154978-VOPP1)

- **omim-611915**: VESICULAR, OVEREXPRESSED IN CANCER, PROSURVIVAL PROTEIN 1; VOPP1. Online Mendelian Inheritance in Man (OMIM). Entry #611915. URL: [https://omim.org/entry/611915](https://omim.org/entry/611915)

- **genecards**: VOPP1 Gene. GeneCards Human Gene Database. URL: [https://www.genecards.org/cgi-bin/carddisp.pl?gene=VOPP1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=VOPP1)


## Citations

1. baras-2010-localization-abstract.md
2. baras-2011-oxidative-abstract.md
3. bonin-2018-vopp1-wwox-breast-fulltext.txt
4. bonin-2018-vopp1-wwox-breast-summary.md
5. gao-2010-mir218-gastric-abstract.md
6. gao-2015-ecop-gastric-oncogene-abstract.md
7. human-protein-atlas-vopp1.md
8. hussain-2018-wwox-interactome-fulltext.txt
9. kertai-2016-vopp1-atrial-fibrillation-abstract.md
10. li-2017-mir218-lung-emt-abstract.md
11. li-2018-mir218-sepsis-abstract.md
12. omim-611915.md
13. park-2005-ecop-nfkb-abstract.md
14. smith-2012-wnv-mirna-abstract.md
15. xia-2013-mir218-glioma-abstract.md